Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

One out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading down 69 points (-0.4%) at 17,966 as of Tuesday, April 21, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,566 issues advancing vs. 1,391 declining with 190 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is unchanged. Top gainers within the industry include

Align Technology

(

ALGN

), up 3.8%,

Omnicare

(

OCR

), up 1.6%,

Grifols

(

GRFS

), up 1.3%,

Fresenius Medical Care AG & Co. KGaA

(

FMS

), up 1.3% and

DaVita HealthCare Partners

(

DVA

), up 1.2%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Aetna

(

AET

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Aetna is up $1.07 (1.0%) to $108.32 on light volume. Thus far, 694,313 shares of Aetna exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $107.57-$108.60 after having opened the day at $107.69 as compared to the previous trading day's close of $107.25.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $37.6 billion and is part of the health care sector. Shares are up 20.7% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Aetna

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Aetna Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Abbott Laboratories

(

ABT

) is up $0.28 (0.6%) to $46.92 on heavy volume. Thus far, 4.1 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $46.72-$47.28 after having opened the day at $46.89 as compared to the previous trading day's close of $46.63.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Abbott Laboratories manufactures and sells health care products worldwide. Abbott Laboratories has a market cap of $69.8 billion and is part of the health care sector. Shares are up 3.6% year-to-date as of the close of trading on Monday. Currently there are 13 analysts who rate Abbott Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Abbott Laboratories

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Abbott Laboratories Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Express Scripts

(

ESRX

) is up $0.62 (0.7%) to $86.40 on light volume. Thus far, 818,825 shares of Express Scripts exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $86.03-$86.88 after having opened the day at $86.21 as compared to the previous trading day's close of $85.78.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. Express Scripts has a market cap of $62.3 billion and is part of the health care sector. Shares are up 1.3% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, revenue growth, reasonable valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Express Scripts Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null